AKTX – Akeso Inc.
AKTX — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
0.52
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
-0.33
EPS This/Next Y
0.03
Price
0.13
Target Price
1
Analyst Recom
1
Performance Q
-52.73
Upside
-13,023.1%
Beta
0.54
Ticker: AKTX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | AKTX | 0.2399 | N/A | N/A | 0 |
| 2026-03-02 | AKTX | 0.2355 | N/A | N/A | 0 |
| 2026-03-03 | AKTX | 0.2334 | N/A | N/A | 0 |
| 2026-03-04 | AKTX | 0.2459 | N/A | N/A | 0 |
| 2026-03-05 | AKTX | 0.2481 | N/A | N/A | 0 |
| 2026-03-06 | AKTX | 0.2535 | N/A | N/A | 0 |
| 2026-03-09 | AKTX | 0.2543 | N/A | N/A | 0 |
| 2026-03-10 | AKTX | 0.257 | N/A | N/A | 0 |
| 2026-03-11 | AKTX | 0.2631 | N/A | N/A | 0 |
| 2026-03-12 | AKTX | 0.2625 | N/A | N/A | 0 |
| 2026-03-13 | AKTX | 0.2567 | N/A | N/A | 0 |
| 2026-03-17 | AKTX | 0.2199 | N/A | N/A | 0 |
| 2026-03-18 | AKTX | 0.1603 | N/A | N/A | 0 |
| 2026-03-19 | AKTX | 0.1432 | N/A | N/A | 0 |
| 2026-03-20 | AKTX | 0.132 | N/A | N/A | 0 |
| 2026-03-23 | AKTX | 0.1444 | N/A | N/A | 0 |
| 2026-03-24 | AKTX | 0.136 | N/A | N/A | 0 |
| 2026-03-25 | AKTX | 0.1354 | N/A | N/A | 0 |
| 2026-03-26 | AKTX | 0.1364 | N/A | N/A | 0 |
| 2026-03-27 | AKTX | 0.1307 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | AKTX | 0.24 | - | 10.3 | -0.33 |
| 2026-03-02 | AKTX | 0.24 | - | 10.3 | -0.33 |
| 2026-03-03 | AKTX | 0.24 | - | 10.3 | -0.33 |
| 2026-03-04 | AKTX | 0.25 | - | 9.9 | -0.33 |
| 2026-03-05 | AKTX | 0.25 | - | 9.6 | -0.33 |
| 2026-03-06 | AKTX | 0.25 | - | 9.6 | -0.33 |
| 2026-03-09 | AKTX | 0.25 | - | 9.8 | -0.33 |
| 2026-03-10 | AKTX | 0.26 | - | 9.5 | -0.33 |
| 2026-03-11 | AKTX | 0.26 | - | 9.6 | -0.33 |
| 2026-03-12 | AKTX | 0.25 | - | 9.9 | -0.33 |
| 2026-03-13 | AKTX | 0.23 | - | 10.5 | -0.33 |
| 2026-03-17 | AKTX | 0.22 | - | 10.6 | -0.33 |
| 2026-03-18 | AKTX | 0.16 | - | 12.3 | -0.33 |
| 2026-03-19 | AKTX | 0.14 | - | 12.8 | -0.33 |
| 2026-03-20 | AKTX | 0.13 | - | 13.0 | -0.33 |
| 2026-03-23 | AKTX | 0.14 | - | 13.1 | -0.33 |
| 2026-03-24 | AKTX | 0.14 | - | 13.1 | -0.33 |
| 2026-03-25 | AKTX | 0.14 | - | 12.8 | -0.33 |
| 2026-03-26 | AKTX | 0.14 | - | 12.8 | -0.33 |
| 2026-03-27 | AKTX | 0.13 | - | 12.9 | -0.33 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | AKTX | 19.19 | 13.61 | 0.77 |
| 2026-03-02 | AKTX | 0.00 | 13.16 | 0.77 |
| 2026-03-03 | AKTX | 0.00 | 13.16 | 0.77 |
| 2026-03-04 | AKTX | 0.00 | 13.16 | 0.77 |
| 2026-03-05 | AKTX | 0.00 | 13.16 | 0.77 |
| 2026-03-06 | AKTX | 0.00 | 13.16 | 0.77 |
| 2026-03-09 | AKTX | 0.00 | 13.16 | 0.77 |
| 2026-03-10 | AKTX | 0.00 | 13.16 | 0.77 |
| 2026-03-11 | AKTX | 0.00 | 13.16 | 0.64 |
| 2026-03-12 | AKTX | 0.00 | 13.16 | 0.64 |
| 2026-03-13 | AKTX | 0.00 | 13.16 | 0.64 |
| 2026-03-17 | AKTX | 0.00 | 13.16 | 0.64 |
| 2026-03-18 | AKTX | 0.00 | 13.16 | 0.64 |
| 2026-03-19 | AKTX | 0.00 | 13.16 | 0.64 |
| 2026-03-20 | AKTX | 0.00 | 13.16 | 0.64 |
| 2026-03-23 | AKTX | 0.00 | 13.16 | 0.64 |
| 2026-03-24 | AKTX | 0.00 | 13.16 | 0.64 |
| 2026-03-25 | AKTX | 0.00 | 13.16 | 0.52 |
| 2026-03-26 | AKTX | 0.00 | 13.16 | 0.52 |
| 2026-03-27 | AKTX | 0.00 | 13.16 | 0.52 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.06
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
Institutional Transactions
13.16
Beta
0.54
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
12
Growth Score
19
Sentiment Score
16
Actual DrawDown %
99.8
Max Drawdown 5-Year %
-99.8
Target Price
1
P/E
Forward P/E
PEG
P/S
P/B
0.18
P/Free Cash Flow
EPS
-0.48
Average EPS Est. Cur. Y
-0.33
EPS Next Y. (Est.)
-0.3
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.01
Return on Equity vs Sector %
-96.9
Return on Equity vs Industry %
-80.6
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.12
EBIT Estimation
12.9
◆
AKTX
Healthcare
$0.13
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
25
Range 1M
3.3%
Sup Dist
0.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
87.6%
EPS NY
20%
52W%
0.3%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+669.2% upside
Upside
+669.2%
Quality
12
Akari Therapeutics PlcSector: Healthcare
Industry: Biotechnology
Employees: 8
Akari Therapeutics, Plc, an oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, colon, and prostate. Its payloads include PH5, which inhibits DNA mismatch repair (MMR) and DNA damage response (DDR) to generate neoepitopes, and PH6, which inhibits DNA transcription in cancer cells and co-opted immune cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Boston, Massachusetts.
AKTX
Latest News
—
Caricamento notizie per AKTX…
stock quote shares AKTX – Akeso Inc. Stock Price stock today
news today AKTX – Akeso Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AKTX – Akeso Inc. yahoo finance google finance
stock history AKTX – Akeso Inc. invest stock market
stock prices AKTX premarket after hours
ticker AKTX fair value insiders trading